Expression and purification of the D4 region of PLD1 and characterization of its interaction with PED-PEA15

Protein Expression and Purification

Volumn 59, Issue 2, 2008, Pages 302-308

  Viparelli, Francesca ^a,b   Doti, Nunzianna ^a,c   Sandomenico, Annamaria ^a,b   Marasco, Daniela ^a   Dathan, Nina A ^a   Miele, Claudia ^d   Beguinot, Francesco ^d   Monti, Simona M ^a   Ruvo, Menotti ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d CNR   (Italy)

Author keywords

Phospholipase; Phosphoprotein enriched in diabetes (PED); Protein protein interaction; SPR

Indexed keywords

PEA15 PROTEIN, HUMAN; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOPROTEIN; SIGNAL PEPTIDE;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR CLONING; PROTEIN TERTIARY STRUCTURE; SURFACE PLASMON RESONANCE;

CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOLIPASE D; PHOSPHOPROTEINS; PROTEIN STRUCTURE, TERTIARY; SURFACE PLASMON RESONANCE;

EID: 42749089546     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.02.012     Document Type: Article

References (21)

1. McDermott M., Wakelam M.J.O., and Morris A.J. Phospholipase D 1,2, Biochem. Cell Biol. 82 (2004) 225-253
2. Besterman J.M., Duronio V., and Cuatrecasa P. Rapid formation of diacylglycerol from phosphatidylcholine: a pathway for generation of a second messenger. Proc. Natl. Acad. Sci. USA 83 (1986) 6785-6789
3. Sung T.C., Zhang Y., Morris A.J., and Frohman M.A. Structural analysis of human phospholipase D1. J. Biol. Chem. 274 (1999) 3659-3666
4. Sung T.C., Altshuller Y.M., Morris A.J., and Frohman M.A. Molecular analysis of mammalian phospholipase D2. J. Biol. Chem. 274 (1999) 494-502
5. Sung T.C., Roper R., Zhang Y., Rudge S.A., Temel R., Hammond S.M., Morris A.J., Moss B., Engebrecht J., and Frohman M.A. Mutagenesis of Phospholipase D defines a superfamily including a trans-golgi viral protein required for poxvirus pathogenicity. EMBO J. 16 (1997) 4519-4539
6. Stuckey J.A., and Dixon J.E. Crystal structure of a phospholipase D member. Nat. Struct. Biol. 6 (1999) 278-284
7. Davies D.R., Interthal H., Champoux J.J., and Hol W.G. The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. Structure 10 (2002) 237-248
8. Leiros I., Secundo F., Zambonelli C., Servi S., and Hough E. The first crystal structure of a phospholipase D. Structure 8 (2000) 655-667
9. Ponting C.P., and Kerr I.D. A novel family of phospholipase D homologues that includes phospholipid synthases and putative endonucleases: identification of duplicated repeats and potential active site residues. Protein Sci. 5 (1996) 914-922
10. Xie Z., Ho W.T., and Exton J. Association of the N- and C-terminal domains of Phospholipase D. J. Biol. Chem. 275 (2000) 24962-24969
11. Xie Z., Ho W.T., and Exton J. Association of the N- and C-terminal domains of Phospholipase D is required for catalytic activity. J. Biol. Chem. 273 (1998) 34679-34682
12. Kam Y., and Exton J.H. Dimerization of phospholipase D isozymes. Biochem. Biophys. Res. Commun. 290 (2002) 375-380
13. Exton J.H. Phospholipase D-structure, regulation and function. Rev. Physiol. Biochem. Pharmacol. 144 (2002) 1-94
14. Zhang Y., Redina O., Altshuller Y.M., Yamazaki M., Ramos J., Chneiweiss H., Kanaho Y., and Frohman M.A. Regulation of expression of Phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J. Biol. Chem. 275 (2000) 35224-35232
15. Vigliotta G., Miele C., Santopietro S., Portella G., Perfetti A., Maitan M.A., Cassese A., Oriente F., Trencia A., Fiory F., Romano C., Tiveron C., Tatangelo L., Formisano P., and Beguinot F. Overexpression of the PED/PEA15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol. Cell. Biol. 24 (2004) 5005-5015
16. Condorelli G., Vigliotta G., Iavarone C., Caruso M., Tocchetti C.G., Andreozzi F., Cafieri A., Tecce M.F., Formisano P., Beguinot L., and Beguinot F. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J. 17 (1998) 3858-3866
17. Condorelli G., Vigliotta G., Trencia A., Maitan M.A., Caruso M., Miele C., Oriente F., Santopietro S., Formisano P., and Beguinot F. Protein kinase C(PKC)-α activation inhibits PKC-ζ and mediates the action of PED/PEA15 on glucose transport in the L6 skeletal muscle cells. Diabetes 50 (2001) 1244-1252
18. Xiao C., Yang B.F., Asadi N., Beguinot F., and Hao C. Tumor necrosis factor-related apoptosis-inducing signaling complex and its modulation by c-Flip and PED/PEA-15 in glioma cells. J. Biol. Chem. 277 28 (2002) 25020-25025
19. Condorelli G., Trencia A., Vigliotta G., Perfetti A., Goglia U., Cassese A., Musti A.M., Miele C., Santopietro S., Formisano P., and Beguinot F. Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA15 anti-apoptotic function. J. Biol. Chem. 277 (2002) 11013-11018
20. Johnsson B., Lofas S., and Lindquist G. Immobilization of proteins to a carboxylmethyl dextran modified gold surface for biospecific interaction analysis in SPR sensors. Anal. Biochem. 198 (1991) 268-277
21. Hill J.M., Vaidyanathan H., Ramos J.W., Ginsberg M.H., and Werner M.H. Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J. 21 (2002) 6494-6504